Breadcrumb Trail Links News Health Canada While health authorities are reassuring Canadians that it’s safe to mix COVID-19 vaccines doses, some appear to be rejecting Moderna for Pfizer Author of the article: Sharon Kirkey Publishing date: Jun 24, 2021 • 4 days ago • 5 minute read • 126 Comments “There may be some brand recognition… Read More »
The U.S. Food and Drug Administration (FDA) is working to review Pfizer’s request to expand authorization for use of its COVID-19 vaccine among adolescents “as quickly and transparently as possible,” an agency spokesperson confirmed to Fox News. “The FDA’s review of Pfizer’s request to amend its emergency use authorization (EUA) in order to expand the… Read More »
Loading the player… Drug makers continue to test the effectiveness of the COVID-19 vaccine. Read More: Johnson & Johnson COVID-19 vaccine batch fails quality check On Thursday, Pfizer and BioNTech revealed its vaccine protects against a variant that drug makers were concerned about, per NBC News. It added that an individual is protected for up… Read More »
Thanks to the success of its COVID-19 vaccine, the drug giant Pfizer has become a household name around the globe—and the company’s eyeing $ 15 billion in sales from the shot this year. For writing that 2020 success story, CEO Albert Bourla collected a pay package worth more than $ 21 million. Bourla, who took… Read More »
Article content continued “I just want to see the evidence.” Canada has bought the rights to 20 million doses of Pfizer’s vaccine. Ottawa, hedging its bets, has also signed pre-order agreements with Quebec-based Medicago, Moderna and other companies for up to 358 million doses of different vaccine candidates. A federal advisory committee has recommended those… Read More »
Pharma companies including Pfizer, Novartis and AbbVie have paused advertising on Facebook for July. Their brands join others in the Stop Hate for Profit campaign, meant to pressure Facebook into taking action against hate and disinformation spread on its platform. Pfizer is the largest of the pharma companies participating and one of three overall top 25… Read More »
A coronavirus vaccine candidate from pharmaceutical company Pfizer has shown potential in healthy volunteers. Stocks jumped on the announcement Wednesday. The experimental vaccine developed by Pfizer and the biotech firm BioNTech produced promising results in early-stage human trials, in which 45 volunteers were given doses of the vaccine. Each participant received 10, 30, or 100… Read More »